Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Novartis Readies For Primary Care Launches, But Sales Expansion Not In Mix

Executive Summary

Novartis hopes a sales force optimization program will allow it to avoid adding additional sales representatives despite near-term launches of primary care products

You may also be interested in...



Overactive Bladder Market New Entrants Are Targeting Specialty Physicians

Recent entrants to the overactive bladder category are focusing on capturing market share through specialty physicians, Indevus Exec VP and Chief Sales & Marketing Officer John Tucker said

Overactive Bladder Market New Entrants Are Targeting Specialty Physicians

Recent entrants to the overactive bladder category are focusing on capturing market share through specialty physicians, Indevus Exec VP and Chief Sales & Marketing Officer John Tucker said

GSK Launching Vesicare, Boniva Without Adding Reps; “Efficiency” Is Key

GlaxoSmithKline is launching Vesicare and Boniva without increasing the size of its sales force

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS046094

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel